Jane Street Group LLC Has $164,000 Holdings in Viemed Healthcare, Inc. (NASDAQ:VMD)

Jane Street Group LLC lessened its position in Viemed Healthcare, Inc. (NASDAQ:VMD) by 75.6% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 22,356 shares of the company’s stock after selling 69,320 shares during the period. Jane Street Group LLC owned approximately 0.06% of Viemed Healthcare worth $164,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Perkins Coie Trust Co purchased a new position in shares of Viemed Healthcare during the third quarter valued at approximately $73,000. PDT Partners LLC purchased a new position in shares of Viemed Healthcare during the third quarter valued at approximately $78,000. Victory Capital Management Inc. boosted its position in shares of Viemed Healthcare by 21.1% during the second quarter. Victory Capital Management Inc. now owns 12,791 shares of the company’s stock valued at $84,000 after buying an additional 2,226 shares during the last quarter. Walleye Capital LLC purchased a new position in shares of Viemed Healthcare during the third quarter valued at approximately $87,000. Finally, SG Americas Securities LLC bought a new stake in Viemed Healthcare during the third quarter worth $89,000. Institutional investors and hedge funds own 74.24% of the company’s stock.

Viemed Healthcare Stock Performance

Shares of Viemed Healthcare stock opened at $7.92 on Tuesday. The business’s fifty day simple moving average is $8.52 and its 200 day simple moving average is $7.89. The firm has a market capitalization of $308.38 million, a P/E ratio of 29.33 and a beta of 1.47. Viemed Healthcare, Inc. has a 12 month low of $6.21 and a 12 month high of $10.44. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03.

Viemed Healthcare (NASDAQ:VMD) last issued its quarterly earnings results on Wednesday, November 6th. The company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of $0.08 by $0.02. The business had revenue of $58.00 million for the quarter. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%.

Insider Buying and Selling at Viemed Healthcare

In related news, Director Randy E. Dobbs sold 36,261 shares of the stock in a transaction dated Wednesday, November 13th. The stock was sold at an average price of $9.28, for a total transaction of $336,502.08. Following the sale, the director now owns 107,706 shares of the company’s stock, valued at approximately $999,511.68. This represents a 25.19 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Nitin Kaushal sold 5,995 shares of the stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $8.58, for a total value of $51,437.10. Following the sale, the director now directly owns 126,843 shares in the company, valued at $1,088,312.94. This trade represents a 4.51 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 72,256 shares of company stock worth $674,739 over the last ninety days. 20.00% of the stock is currently owned by company insiders.

Viemed Healthcare Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.